Werbung
Anlageziel
Carnegie Medical is a Sub Fund of the CARNEGIE FUND, an unincorporated open-ended collective investment fund registered in Luxembourg under Part 1 of the Law of December 20, 2002. The investment objective of the Sub Fund is to achieve long-term capital growth through global investment in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors. The Sub Fund will focus particularly on large-cap companies which will account for at least 75% of the Sub Fund?s value and also on small-cap companies which may represent up to 25% of the Sub Fund?s value.
Stammdaten
| Name | C WorldWide Medical 2A Fonds |
| ISIN | LU0121135528 |
| WKN | |
| Fondsgesellschaft | C WorldWide Fund Management S.A. |
| Benchmark | MSCI World/Health Care |
| Ausschüttungsart | Thesaurierend |
| Manager | Mikael Svensson, Ulf Arvidsson |
| Domizil | Luxembourg |
| Fondskategorie | Aktien |
| Auflagedatum | 18.12.2000 |
| Geschäftsjahr | 31.12. |
| VL-fähig? | Nein |
| Depotbank | Bank of New York Mellon (Luxembourg) S.A. |
| Zahlstelle | UBS Fund Services (Lux) SA |
| Riester Fonds | Nein |
Basisdaten
| Auflagedatum | 18.12.2000 |
| Depotbank | Bank of New York Mellon (Luxembourg) S.A. |
| Zahlstelle | UBS Fund Services (Lux) SA |
| Domizil | Luxembourg |
| Geschäftsjahr | 31.12. |
Aktuelle Daten
| Morningstar Rating | |
| Aktueller Rücknahmepreis | 2.063,36 |
| Anzahl Fonds der Kategorie | 820 |
| Volumen der Tranche | 9,15 Mio. NOK |
| Fondsvolumen | 777,10 Mio. NOK |
| Total Expense Ratio (TER) | 0,72 |
Gebühren
| Laufende Kosten | 0,88% |
| Total Expense Ratio (Verwaltungsgebühren & sonst. Kosten) | 0,72% |
| Transaktionskosten | 0,16% |
| Depotbankgebühr | - |
| Managementgebühr | 1,50% |
| Rücknahmegebühr | - |
| Ausgabeaufschlag | 3,00% |
Performancedaten
| Veränderung Vortag | -6,61 |
| WE seit Jahresbeginn | -8,64% |